Clinical Trial Update: Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the combination of sintilimab and tafolecimab with chemotherapy as first-line treatment for extensive-stage small cell lung cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)
• Tafolecimab

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Extensive-stage Small Cell Lung Cancer (ES-SCLC), Extensive Stage Lung Small Cell Cancer | Phase 2 | Status: NOT_YET_RECRUITING